Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
52 hedge funds and large institutions have $72.1M invested in Psychemedics Corporation in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 2 closing their positions.
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
18% more capital invested
Capital invested by funds: $61M → $72.1M (+$11.1M)
18% more funds holding
Funds holding: 44 → 52 (+8)
7% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q4 2016 in Review
52 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q4 2016, worth a combined $72.1M — up 18% from $61M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new PMD positions and 2 closed out — a net gain of 8 holders — while 16 added to existing stakes and 15 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.46M. The largest seller was Uniplan Investment Counsel, cutting an estimated $4.61M.
- 52 institutional investors held Psychemedics Corporation (PMD) as of Q4 2016, up from 44 in Q3 2016.
- Funds reported $72.1M of Psychemedics Corporation stock for Q4 2016, up 18% quarter-over-quarter.
- 10 funds opened new Psychemedics Corporation positions in Q4 2016 and 2 closed out, a net change of +8 holders.
- The largest Psychemedics Corporation buyer in Q4 2016 was Renaissance Technologies, an estimated $1.46M added.
- The largest Psychemedics Corporation seller in Q4 2016 was Uniplan Investment Counsel, an estimated $4.61M sold.
Based on aggregated 13F filings for Q4 2016.